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Introduction
Nasal and paranasal malignant tumors invading the skull base are relatively rare, accounting for $3 to 5% of all malignant head and neck tumors. 1 In view of the rarity of cancer developing at this anatomical site and due to the multiplicity of histological types, no randomized clinical trials have been completed to generate treatment recommendations. Operative mortality rates are reported to be <5%, but the overall complication rate for craniofacial resection (CFR) has been reported to range from 25 to 65%. [2] [3] [4] [5] [6] Recently, chemoradiotherapy (CRT) and particle radiotherapy have been employed as alternative treatment options for these cancers in patients who decline CFR. Skull base surgery can be employed as a rescue treatment for recurrent cancers. Yet, in our previous study, we reported that postoperative complications were significantly higher in patients who first underwent radiotherapy with a dose of more than 60 Gy. Similarly, severe complications are also expected in patients who undergo particle radiotherapy, but to date, no report has focused on the postoperative complications of skull base surgery after concomitant CRT or particle therapy.
Methods
A retrospective analysis was conducted in patients with nasal or paranasal sinus tumors invading the skull base, who had been surgically treated at Kobe University Hospital between 1993 and 2015. A total of 26 men and 22 women were included in the analysis, with an average age of 59 years (range, 13À73 years). Forty-seven patients underwent 48 skull base surgeries for tumors involving the skull base during this period. Thirty patients had the following treatments prior to skull base surgery: CRT (n ¼ 15), radiotherapy (n ¼ 3), particle radiotherapy (n ¼ 4), chemotherapy (n ¼ 5), and surgery (n ¼ 3). All patients had malignant tumors, and squamous cell carcinoma was the most common pathology (squamous cell carcinoma [n ¼ 21], olfactory neuroblastoma [n ¼ 13], adenocarcinoma [n ¼ 5], and others [n ¼ 9]). Follow-up periods after treatment ranged from 1 to 215 months (median, 36 months). Overall survival rates, disease-free survival rates, and local control rates were calculated using the Kaplan À Meier method. For statistical analysis, Fisher's exact probability test was used, and p < 0.05 was considered statistically significant.
Results

Surgical Management
The surgical approach was classified based on the extent of resection required. ►Fig. 1 illustrates pattern of dissection. ►Fig. 1A included en bloc resection of the tumor, involving the ethmoid and/or sphenoid sinuses. A bifrontal craniotomy was performed to access the anterior skull base, incorporating the most medial aspect of the tumor involving the anterior skull base. Orbital contents were preserved in this procedure. Defects in the anterior skull base were reconstructed with a pericranial flap. ►Fig. 1B used an infratemporal-subtemporal approach via a frontolateral craniotomy and total maxillectomy with infratemporal dissection, through a classic or modified Weber-Fergusson incision. Any defect in the anterolateral skull base was reconstructed using a free flap of rectus abdominal muscle. Procedures for ►Fig. 1A and B were performed in 21 and 23 patients, respectively. Atypical approaches were performed on the remaining patients.
Oncological Outcome, Postoperative Mortality, and Major Complications Kaplan-Meier curves for local control rate, disease-free survival rate, and overall survival rate are given in ►Fig. 2. The 5-year local control rate, disease-free survival rate, and overall survival rate were 76%, 55.6%, and 66.7%, respectively.
In our series of 47 patients undergoing surgery for nasal and paranasal malignant tumors involving the skull base, one (2.1%) patient died perioperatively due to a lung infarction. Major postoperative complications were observed after 14 (29.7%) surgical procedures. Two or more complications were observed in four patients. Postoperative complications are reported in ►Table 1. Complications involving the central nervous system occurred in 14 (29.2%) patients, systemic complications occurred in one (2.4%) patient, and wound complications were observed in 10 (21.2%) patients. Postoperative complications according to patients' variables predictive for mortality are shown in ►Table 2. Patients >60 years of age and previous treatments were not significant predictors of postoperative complications. However, previous radiotherapy or CRT was a significant predictor of postoperative complications (p < 0.03). 
Major Postoperative Complications According to Extent of Surgery
Postoperative complications according to surgical extent, as predictors of mortality, are shown in ►Table 3. There were no significant differences in complications associated with resection of the orbit, frontal lobe, or dura mater. However, ►Fig. 1B (anterolateral skull base) resection had a significantly higher rate of complications compared with a ►Fig. 1A (anterior skull base) resection. Abbreviation: NS, non-significant.
Major Postoperative Local Complications According to RT, CRT, or Particle Therapy
►Table 4 summarizes the major postoperative complications according to prior RT, CRT, or particle radiotherapy. Nine (50%) of 18 patients treated with prior radiotherapy or CRT had postoperative complications, and 2 (50%) of 4 patients treated with particle radiotherapy also had severe postoperative complications. In particular, patients who received >60 Gy of radiotherapy or particle radiotherapy had more severe complications. For example, one patient had encephalitis, three had CSF leakage, and one had unresectable calcification of the dura.
Discussion
In this report, we analyzed oncological outcomes and perioperative complications in patients who underwent skull base surgery at our hospital. We found that prior radiotherapy, CRT, or particle radiotherapy as well as the extent of surgery required were significant predictors of severe postoperative complications. a complication rate of 50.5%. 8 At our institution, one patient died due to lung infarction. Following this, we stopped introducing a femoral central intravenous catheter during the perioperative period and gave particular attention to the possibility of deep vein thrombosis. Reported causes of postoperative death include systemic disease, such as acute myocardial infarction, unexpected variceal bleeding due to liver cirrhosis, and cerebrovascular complications, such as infarction of the brain, cerebral edema, and rupture of the internal carotid artery.
7,8
The presence of a medical comorbidity, prior radiation exposure, and both dural and brain involvement were also reported to be associated with severe complications. 3 In the present study, prior irradiation was an important predictive factor of postoperative complications, in accordance with our previous study. 6 We also found that prior particle radiotherapy was a predictive factor for postoperative complications. Patel et al. 9 showed the physical advantage of a rapid dose fall-off beyond the Bragg peak, which allows more conformal treatment with a better targeted dose-coverage of nasal and paranasal tumors. However, as is evident from the present study, particle therapy resulted in poor survivability and frequent postoperative complications. All patients with prior CRT or particle radiotherapy in our series refused skull base surgery as the initial therapy and received these treatments at other hospitals. However, the previously reported skull base survival rates of patients with squamous cell carcinoma involving skull base invasion, who were treated with particle radiotherapy or CRT, were significantly poorer than those of such patients in the present series.
10,11 Considering these results, we highly recommend skull base surgery as the initial treatment for patients with nasal and paranasal malignant tumors involving the skull base.
In the present study, types of skull base resections had significant correlations with postoperative complications. Anterolateral resection required reconstruction with a free musculocutaneous flap as well as a longer operating time. Consequently, complications associated with the use of free flaps, such as necrosis and epidural abscesses, developed. Taken together, several factors contributed to the occurrence of postoperative complications associated with anterior and anterolateral cranial base surgery. This includes the extent of the surgical approach, whether more than a single surgery was required, prior radiotherapy or CRT, and the experience of the surgical team. As is shown in ►Table 1, the most common postoperative complication was epidural abscess. To avoid the occurrence of this complication and to protect the reconstructed dura using an adequate volume of wellvascularized muscle tissue, careful attention needs to be paid to obliterating the skull base defect. In addition, the mucosal remnant of the frontal sinus should be removed in order to prevent sinusitis, and a drainage route from the skull base to the nasal cavity should be secured to prevent epidural fluid accumulation.
Recently, endoscopic endonasal surgery and endoscopicassisted skull base surgery for nasal and paranasal tumors invading the skull base have been reported, with excellent oncological and functional results.
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advisable that patients with nasal and paranasal malignancies involving the skull base should be treated with these advanced forms of skull base surgery to avoid unnecessary postoperative complications and to afford good control of tumors.
Conclusion
Patients who underwent definitive CRTor particle radiotherapy were at significantly higher risk of severe postoperative complications after skull base surgery; these patients, therefore, require meticulous care.
